Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06515938
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-17
Brief Title:
Study on New Strategies for Hepatitis B Virus Immunization
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparative Immunogenicity of Hepatitis B Vaccine With Different Immunization Schedule in Primary Immune Adults Aged 25-55 in China
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the immunogenicity of HB vaccine with different series among primary immune adults aged 25-55 to assess potential alternative approaches for HB immunization
Detailed Description:
By comparing the immunization effect of hepatitis B vaccine with other different types of hepatitis B vaccines using seris procedure information on the immunization effect of 60 micrograms of hepatitis B vaccine in adults was obtained which will provide a scientific basis for the development of a rapid immunization procedure for adults with large doses of hepatitis B vaccine and for the improvement of the immunization strategy for hepatitis B in adults
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: